Credits: Canva
10 Obese States in the US: As per the World Health Organization, overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health. A body mass index (BMI) over 25 is considered overweight, and over 30 is considered obese. This has been one of the most persistent public health concerns in the US. According to a study by the Centers for Disease Control and Prevention (CDC), around 40% of US adults are affected by obesity in the two-year period that ended in August 2023.
Among the 48 states, 23 had an adult obesity prevalence at or above 35% as per the CDC data survey. Of them, 3 states reported a rate of 40%. The data was compared with 2013 and it found that no state had an adult obesity rate at or above 35% back then.
As per the CDC, the most obese states spend approximately $173 billion annually on healthcare for conditions like diabetes, heart disease, cancer, stroke, and respiratory illness.
The rates of non-Hispanic Black adults were 35% in 38 states, the rates reached that level among Hispanic adults in 34 states and among American Indian or Alaska Native adults in 30. While adults only had obesity rates of at least 35% in 16 states, while Asian adults did not meet the threshold.
1. West Virginia at 41.7%
2. Arkansas at 40.5%
3. Mississippi at 40.4%
4. Louisiana at 39.9%
5. Alabama at 39.4%
6. Oklahoma at 39.0%
7. Iowa at 37.9%
8. Indiana at 37.8%
9. Tennessee at 37.8%
10. Nebraska at 36.5%
As per the National Health and Nutrition Examination Survey of 2017-2018, nearly 1 in 3 adults in the US are overweight. More than 2 in 5 adults have obesity and 1 in 11 adults have severe obesity. The data also presents that 1 in 6 children and adolescents ages 2 to 19 are overweight. Almost 1 in 5 children and adolescents ages 2 to 19 have obesity and about 1 in 16 children and adolescents ages 2 to 19 have severe obesity.
Living with obesity can increase the risk of several chronic health conditions. These may include type 2 diabetes and cancer. Obesity is often associated with a reduced quality of life and poor mental health. Studies have shown that this happens because of the social stigma that exists around weight that is faced by people and this is why they do not seek for help.
A study published in the Journal of Nutrition in November 2024, studied over 10,000 adults and found that a higher waist circumference, waist-to-height ratio, and BMI, were associated with a higher risk of type 2 diabetes. The study also found that those with the greatest increases in body weight or waist circumference over an average of 2.8 years had an approximately 1.5-and1.4-fold greater risk of developing type 2 diabetes, respectively.
The number of calories consumed by people in North America and Europe has been rising since 2000, it has reached to 3,540 per day in 2021, as per the United Nations (UN). The number of calories consumed is greater than the number of calories the body can burn, this is why the body stores the extra energy as fat, and this is what results to weight gain. Processed food further contains excess of sodium, sugar, and fat, which contains way more calories than needed. Furthermore, eating refined sugar can also raise your insulin and make you hungrier, causing you to eat more.
Credits: Canva
Individuals using one of the UK’s most frequently prescribed painkillers should know about a rare side effect that can cause a severe burning sensation in the stomach. While this medication is widely used and taken regularly by many, health experts have now issued a warning regarding this potential reaction.
Naproxen is a non-steroidal anti-inflammatory drug (NSAID), part of the same group as ibuprofen and aspirin. It helps reduce pain, inflammation, and swelling in muscles and joints. Doctors may prescribe it in tablet or liquid form for conditions like rheumatoid arthritis, osteoarthritis, gout, and menstrual cramps.
It’s also used to treat certain muscle or bone problems, including back pain, sprains, and strains. The duration of treatment can vary, some people only need a few days, while others may require longer-term prescriptions. If you take naproxen for an extended period, your doctor may also prescribe medication to reduce the risk of side effects.
According to the NHS, your naproxen dose depends on why you are taking it, your age, liver and kidney function, and how well it relieves your symptoms. Older adults and people with heart, liver, or kidney issues usually receive lower doses. For children, the dose is calculated based on weight.
Like all medications, naproxen can cause side effects, though not everyone experiences them. Common issues, affecting about 1 in 100 people, include:
If any side effect persists or causes discomfort, speak with a doctor or pharmacist. In rare cases, naproxen can lead to severe stomach problems, such as intense indigestion, heartburn, or abdominal pain, which may indicate an ulcer or inflammation, according to the NHS.
The NHS website claims: "Your doctor may tell you not to take naproxen if you have a stomach ulcer or you have had one in the past. If you need to take naproxen but are at risk of getting a stomach ulcer, your doctor may prescribe another medicine for you to take alongside naproxen to protect your stomach.”
The most common symptom of a stomach ulcer is a burning or gnawing pain in the centre of the stomach. But stomach ulcers are not always painful and some people may have other symptoms, such as indigestion, heartburn and feeling sick.
If you think you may have symptoms of a stomach ulcer, stop taking naproxen and contact your doctor. You can report any suspected side effect using the Yellow Card safety scheme.
Credits: Canva
The US Food and Drug Administration has given the green light to a new once-daily pill that works without hormones to ease moderate to severe hot flashes in menopausal women, Bayer announced Friday. The drug, called elinzanetant, will be available in the US starting in November under the brand name Lynkuet, according to Bayer.
It works by targeting brain chemicals responsible for hot flashes and night sweats, medically referred to as vasomotor symptoms. Experts estimate that over 80% of women experience hot flashes during menopause.
“This FDA approval marks a bold leap forward, our first non-hormonal treatment for vasomotor symptoms of menopause,” said Christine Roth, Bayer’s executive vice president of global product strategy and commercialization, in a news release Friday. “There’s a growing need for personalized approaches to menopause care, and Lynkuet fills a crucial gap in treatment options.”
For many women, hormone therapy can be a safe and effective way to manage symptoms like hot flashes. However, some women with certain health conditions or a history of diseases, including specific cancers, are sometimes advised against hormone replacement therapy. In such cases, alternative options like Lynkuet may be particularly valuable.
A Phase 3 clinical trial involving 628 postmenopausal women found that those taking elinzanetant for 12 weeks saw more than a 73% reduction in the frequency of their vasomotor symptoms, compared with a 47% reduction in those who received a placebo. The most commonly reported side effects were drowsiness, fatigue, and headaches.
“This year-long study not only confirmed rapid and substantial relief from the frequency and severity of hot flashes and night sweats but also showed that these benefits lasted for a full year, offering hope for long-term symptom control,” said Dr. JoAnn Pinkerton, director of midlife health at UVA Health and emeritus executive director of the North American Menopause Society, when the trial results were published.
“For women facing moderate to severe vasomotor symptoms during menopause, treatment options have been limited, especially for those who cannot or prefer not to use hormone therapy,” Pinkerton added. “Severe hot flashes can disrupt daily life, work, and home routines, highlighting the need for effective non-hormonal treatments.”
Hot flashes are sudden, intense feelings of heat that usually affect the face, chest, and head. They can bring on heavy sweating and flushing for several minutes. Nighttime episodes are called night sweats. Women can experience hot flashes sporadically or multiple times a day, making them highly disruptive.
“It’s important that women know there are choices to treat moderate to severe hot flashes, and this approval gives healthcare providers another option,” said Claire Gill, president and founder of the National Menopause Foundation, in Bayer’s announcement.
In 2023, the FDA approved another non-hormonal menopause drug, fezolinetant, which also provides an alternative to traditional hormone therapies for hot flashes. Fezolinetant and elinzanetant are among the first drugs to target a recently discovered brain pathway involved in regulating hot flashes.
During menopause, declining estrogen levels trigger overactive nerves in the hypothalamus, a small region deep in the brain that helps control the body’s thermostat. These nerves release too many chemical signals called neurokinins. Both drugs block neurokinin receptors on brain cells, reducing the signals that trigger hot flashes.
“Severe hot flashes can significantly affect daily life,” Pinkerton said. “This approval gives healthcare providers a new, first-line option to help women with moderate to severe menopause-related hot flashes.”
Credits: Canva
Health officials in the UK have issued a 48-hour warning after a rise in cases of an “unpleasant” winter bug. The UK Health Security Agency (UKHSA) has urged people to stay home for two days after symptoms subside to help stop the spread of norovirus, commonly known as the “winter vomiting bug.” The virus, which causes vomiting and diarrhoea, spreads easily, particularly in colder months.
Recent data shows that cases have started to climb across England in recent weeks. The NHS has supported the UKHSA’s advice, reminding people to remain at home for at least 48 hours after symptoms clear to avoid infecting others.
Norovirus is a highly contagious group of viruses that cause sudden vomiting and diarrhea. It spreads easily through contaminated food, water, and surfaces, and is known to peak during the colder months. In fact, it’s the leading cause of foodborne illness in the United States.
The virus was first identified in 1968 after an outbreak in an elementary school in Norwalk, Ohio, which gave it its original name, the Norwalk virus.
Although often called the “stomach flu,” norovirus is not related to influenza. The flu virus affects the respiratory system, while norovirus targets the digestive tract, causing gastroenteritis.
Norovirus belongs to the Caliciviridae family and includes 10 groups with around 48 known types. Among these, the GII.4 strain is the one most often linked to widespread outbreaks.
Here are some less-covered but important unique symptoms of Norovirus infection to watch for:
Unusual how quickly it hits and how short-lived it often is: many people recover in 1-3 days, yet they can still spread the virus for days after symptoms stop
To help stop the virus from spreading, the NHS has urged people with symptoms to take extra care, as per NHS. Those affected should:
Contaminated food and water can also transmit the virus. Along with staying home while you’re unwell, the NHS recommends taking the following precautions to reduce the risk of passing it on:
Wash your hands thoroughly with soap and warm water after using the toilet or changing nappies, alcohol-based hand gels do not kill norovirus.
© 2024 Bennett, Coleman & Company Limited